Tus kws kho mob
QP5-25 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective February 1, 2025
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 22, 2025
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2931 - 2940 ntawm 4374
Tus kws kho mob
P6-25 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans Managed by Blue Cross and Blue Shield of Alabama
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 03, 2025
Tus kws kho mob
P7-25 Prime Therapeutics Management (UM) Program: Medical Drug Updates
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 03, 2025
Tus kws kho mob
P8-25 Update to Reimbursement Policy: Commercial General Coding 074 Cellular and Gene Therapy Product
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 03, 2025
Tus kws kho mob
2025 February Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 03, 2025
Tus kws kho mob
QP42-25 MHCP Pharmacy Benefit Exclusion for Encelto™ and Ryoncil®
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 14, 2025
Tus kws kho mob
QP41-25 Commercial Pharmacy Benefit Exclusion for Encelto™, Epysqli® and Ryoncil®
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 14, 2025